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A B S T R A C T
Introduction: Tablets are frequently subdivided to lower the dose, to facilitate swallowing by e.g. children
or older people or to save costs. Splitting devices are commonly used when hand breaking is difﬁcult or
painful.
Methods: Three techniques for tablet subdivision were investigated: hand breaking, tablet splitter,
kitchen knife. A best case drug (paracetamol), tablet (round, ﬂat, uncoated, 500 mg) and operator (24-
year student) were applied. Hundred tablets were subdivided by hand and by three devices of each of the
following types: Fit & Healthy, Health Care Logistics, Lifetime, PillAid, PillTool, Pilomat tablet splitter;
Blokker kitchen knife. The intra and inter device accuracy, precision and sustainability were investigated.
The compliance to (adapted) regulatory requirements was investigated also.
Results: The accuracy and precision of hand broken tablets was 104/97% resp. 2.8/3.2% (one part per tablet
considered; parts right/left side operator). The right/left accuracies of the splitting devices varied
between 60 and 133%; the precisions 4.0 and 29.6%. The devices did not deteriorate over 100-fold use.
Only hand broken tablets complied with all regulatory requirements.
Conclusion: Health care professionals should realize that tablet splitting may result in inaccurate dosing.
Authorities should undertake appropriate measures to assure good function of tablet splitters and, where
feasible, to reduce the need for their use.
ã 2014 The Authors. Published by ELSEVIERCOMPANY. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Breaking or splitting tablets is common practice in inpatient
and outpatient settings as it increases dosing ﬂexibility, facilitates
swallowing and allows cost savings for both patients and health-
care providers (Dormuth et al., 2008; Ekedahl, 2013; Freeman et al.,
2012b; Quinzler et al., 2006; Rodenhuis et al., 2004).
However, patients have indicated that it may be difﬁcult and
painful to break tablets by hand (Ekedahl, 2013; van Santen et al.,
2002). This is especially true for patients with impaired hand
function such as (school) children and older people (patient
populations who often need lower doses or dose titrations) or
patients suffering from rheumatic diseases (Barends et al., 2005;
Ekedahl, 2013; Mehuys et al., 2012; Wilson et al., 2001). Ekedahl for
example concluded that 31% of Swedish adult patients experiencedrticle under the CC BY license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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of home dwelling older adults experienced difﬁculties when they
had to subdivide tablets and Barends et al. concluded that older
Dutch people were far less able to break tablets by hand than
healthy adult volunteers. Wilson et al. reported a mean pain score
of 3.2 out of 10 for generic anti-diabetic tablets when hand broken
by older American citizens.
As breaking tablets by hand is often considered problematic, the
use of tablet splitters is common. This is especially true for tablets
that do not have a break mark. Other splitting devices such as
kitchen knives or scissors may be applied as well (Ekedahl, 2013;
Quinzler et al., 2009; Tahaineh and Gharaibeh, 2012).
Indexed publications on the accuracy and precision of tablet
splitters, kitchen knives or other devices that may be applied to
subdivide tablets (all further referred to as “splitting devices”)
generally show limitations as e.g. uncertainties about the type of
device, operator or weight measurements applied; random
selection of the device and tablet types; only small numbers of
tablets/devices tested and the lack of data comparison between
tablets subdivided with a splitting device and those broken by
hand. Consequently, it is not yet possible to draw a ﬁrm conclusion
on the suitability e.g. accuracy, precision, sustainability of splitting
devices as an alternative to breaking tablets by hand.
In addition, the conclusion of Freeman’s review that tablet
splitters may not subdivide tablets into equal doses and that the
accuracy of tablet splitters may depend on the type of splitter, tablet
or operator applied needs further consideration as the review shows
methodological shortcomings such as no information on search
proﬁle, data extraction and data analysis and no qualityevaluation of
the included publications (Freeman et al.,2012a).
Therefore, the primary objective of this study was to evaluate
the accuracy, precision and sustainability of commercially
available tablet splitters and a kitchen knife as an alternative to
breaking tablets by hand. The secondary objective was to evaluate
if tablets subdivided with a splitting device were likely to comply
with current regulatory requirements for break marked tablets
(European Directorate for the Quality of Medicines (EDQM), 2013;
European Union, 2001; US Department of Health and Human
Services, FDA, 2011).Fig. 1. Characteristics 2. Material and methods
2.1. Study design
In this experiment three techniques for tablet subdivision were
compared: hand breaking, tablet splitter, and kitchen knife. A
hundred paracetamol tablets were hand broken by a single
operator, by three devices of several types of tablets splitters or by
three kitchen knives of the same type. The suitability of the
techniques was compared by evaluation of the accuracy, precision,
sustainability and regulatory compliance of the weight measure-
ments. The experiment did not require ethical approval according
to the Dutch Medical Research Involving Human Subjects Act
(WMO). The study protocol was approved by the Committee on
Clinical Practice of the Medicines Evaluation Board in the
Netherlands.
2.2. Methodology
All data were collected between November 2012 and February
2013.
Splitting devices: Tablet splitters were included if these were
available in the standard assortment of at least two community
pharmacies or drug stores in Utrecht, the Netherlands. The
pharmacies were identiﬁed via a list of the Dutch Society for
the Advancement of Pharmacy (KNMP) whereas drug stores were
identiﬁed via the Dutch Trading Register or the internet. Thirty ﬁve
pharmacies and 59 drug stores were identiﬁed, selling 15 types of
tablet splitters. Five tablet splitters were excluded because these
were not in the pharmacy’s standard assortment and another four
because these were sold in one establishment only. Six types of
tablet splitters were included. The kitchen knife was purchased at a
household warehouse in Utrecht (national chain) (Fig. 1).
Drug compound and tablet trade mark: Marketing author-
isations for round, ﬂat, uncoated, break marked 500 mg paraceta-
mol tablets were identiﬁed with help of the database of the
Medicines Evaluation Board in the Netherlands (MEB). The
retrieved tablet authorisations were categorized in groups with
authorisations for tablets sharing the same manufacturer andsplitting devices.
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(household vernier calliper gauge) and resistance to crushing
(Heberlein diametral compression test apparatus; 2E/205 Schleu-
niger Productronic AG, Solothurn, Switserland) of the commer-
cially available tablets was assessed (n = 10). The results from all
groups were compared and a tablet with “average” characteristics
i.e. Paracetamol Centrafarm RVG 53055 was selected.
Operator: A best case operator with adequate understanding of
the study principles and good hand function was selected i.e. a
healthy, female, 24-years old master student in her 5th year of
pharmaceutical sciences at Utrecht University (MD).
Weight measurements: The weight of 100 intact tablets was
determined (Mettler Toledo AG64 analytical balance). The average
weight (further referred to as “theoretical intact tablet weight”)
and standard deviation were 619.775 mg; 4.152 mg. The theoretical
weight of a tablet part was calculated as half the theoretical intact
tablet weight i.e. 309.888 mg.
2.3. Data collection
The key characteristics of each tablet splitter (name, appear-
ance, shape tablet holder, position tablet holder, shape knife,
price), kitchen knife (name, appearance) were extracted. The
weights of both parts of each subdivided tablet were determined
(Mettler Toledo AG64 analytical balance). It was recorded whether
a tablet part resulted from the right or left side of the splitting
device or the operator’s hands.
2.4. Data analysis: accuracy, precision, sustainability
Five approaches were used to the selection of the tablet parts to
be considered in the data analysis: 1) The intra device accuracy was
calculated as the percent of the average weight of 100 parts
obtained from the right side of a splitting device (where the parts
from the left side were rejected) versus the theoretical weight of a
tablet part. The inter device accuracy was calculated in the same
way as the average weight of 300 parts obtained from the right side
of the three devices of the same type (where the parts from the left
side were rejected). The intra and inter precision were calculated
likewise as the relative standard deviations of the weight
measurements; 2) As approach 1, however now the left sides
were considered and the right sides rejected; 3) As approach 1,
however the tablet parts were no longer grouped depending on the
side of the splitting device these originated from, but in those
weighing the least or most following subdivision. The tablets with
the lowest weight were considered (and those with the highest
weight rejected); 4) As approach 3, however now the tablets with
the highest weight were considered (and those with the lowest
weight rejected); 5) As approach 1, however now both parts from
each tablet were considered.
All results were compared with those of tablets broken by hand
(multiple t-tests; analysis of variance with type of splitting device
and device as factors, with the latter nested within the former,
followed by Dunnett’s posthoc analysis). The sustainability of the
splitting devices over 100-fold use was inspected visually
(integrity of the device, trends in weight variability).
2.5. Regulatory requirements
Uniformity of weight of tablet parts as adapted from Ph. Eur. 478
subdivision of tablets: Both parts of the same tablet were
considered. It was evaluated if the weight of the parts complied
with the following criterion “at least 194 of 200 parts resp. 582 of
600 parts should be within 85–115% and all parts within 75–125%
of the theoretical weight of a tablet part” (European Directorate for
the Quality of Medicines (EDQM), 2013).Simulated assay as adapted from Directive 2001/83/EC: It was
evaluated if the mean weight of parts obtained from the same side
of the operators hands or a splitting device would be within
95.0–105.0% of the theoretical weight of a tablet part i.e. if the
accuracy would be 95.0–105.0% (European Union, 2001).
Loss of mass as adapted from FDA: For each tablet, the loss of
mass was calculated by subtracting the weight of the right and left
part of a tablet from the theoretical intact tablet weight. The loss of
mass of each tablet should be smaller than 3.0% (US Department of
Health and Human Services, FDA, 2011).
3. Results
3.1. Accuracy, precision, sustainability
The intra and inter accuracies of tablets broken by hand or a
splitting device are displayed in Table 1. The accuracy of hand
broken tablets was 104/97% (right/left side operator i.e. R/L); 96/
104% (lowest/highest weight i.e. L/H); 100% (both sides). The
accuracies of the splitting devices varied between 60 and 133% (R/
L); 59 and 133% (H/L); 94 and 100% (both). The largest difference
between sampling R/L versus L/H was observed for the Fit &
Healthy device 1: 96.3/93.6% (R/L) resp. 81.4/108.5% (L/H). Results
for the intra and inter precision are displayed in Table 2. The
precision for hand broken tablets varied between 2.4% (lowest
parts considered) and 4.7% (both parts considered). The precision
of tablets subdivided by a splitting device was 29.6% at the
maximum when parts from one side were considered only (Fit &
Healthy device 2; left parts). Overall, the accuracy and precision of
three types of tablet splitters (Fit & Healthy, Lifetime, PillAid) were
less favourable than the kitchen knife.
Comparing all parts derived from the same side of a splitting
device with those broken by hand from the corresponding side of
the operator, Dunnett’s posthoc analysis showed a statistical
difference in the following cases when the tablets were grouped
per side of device: Lifetime (both p < 0.000), PillTool (p = 0.032;
p = 0.001), Health Care Logistics (p = 0.002; p < 0,000), PillAid (right
p = 0.001) and Fit & Healthy splitter (left p 0 0.000).
Visual evaluation of the splitting devices did not show any
deterioration over 100-fold use and the devices still worked. In one
single case (PillAid device 2) the knife detached from the device
during the experiment. The knife was put back again anticipating
that this approach would also be carried out by patients. No trends in
weight variability of the tablet parts were observed over 100-fold use
(Fig. 2).
3.2. Regulatory requirements
The uniformity of weight of tablet parts broken by hand or
subdivided by the Health Care Logistics or PillTool splitter types
complied with the adapted Ph. Eur. test. The other types of devices
did not comply (Table 3).
The accuracy of tablet parts broken by hand and those subdivided
by the Health Care Logistics, PillAid, PillTool or Pilomat tablet splitter
complied with the simulated assay criteria of 95.0–105.0% when the
parts were sampled from the same side of the operator and when the
overall type of tablet splitter was considered (Table 3). When the 21
devices were considered separately and when all ﬁve approaches to
the selection of the tablet parts were taken into consideration, then
only tablets broken by hand and by the Health Care Logistics splitter
complied in every case (Table 2).
Tablets broken by hand complied with the adapted FDA test for
loss on mass of maximum 3% (Table 3) whereas no of the seven
types of splitting devices complied. When the 21 devices were
considered separately, also tablets subdivided by the Pilomat
device 1 complied (data not shown).
Table 2
Intra and inter precision of paracetamol tablets broken by hands (n = 100), several types of tablet splitters or a kitchen knife (n = 100 per device; three devices per type
investigated).
Splitting technique Number device
tested
Precision (% RSD) for ﬁve different approaches to the selection of the tablet parts to be considered
Right parts only Left parts
only
Lowest weight of both parts
only
Highest weight of both parts
only
Both parts
Hand broken nap 2.78 3.15 2.74 2.43 4.66
Tablet
splitter
Fit & healthy 1 20.31 20.74 21.31 8.52 20.52
2 16.90 29.59 25.81 9.91 26.79
3 16.69 23.14 20.58 10.04 21.33
all 18.47 25.06 24.56 19.46 22.99
Health care
logistics
1 4.52 4.62 3.48 2.78 4.59
2 4.46 3.99 3.96 3.18 5.78
3 4.42 4.36 3.48 2.37 4.50
all 4.73 4.54 3.70 2.85 4.98
Lifetime 1 14.55 5.68 14.47 5.65 30.28
2 12.84 6.06 12.75 6.00 21.28
3 6.72 8.75 8.71 6.69 17.39
24.42 18.13 24.42 18.13 23.54
PillAid 1 25.67 11.16 24.94 9.16 40.96
2 13.56 24.72 23.67 12.58 27.22
3 8.76 14.24 11.13 6.63 23.60
all 31.37 31.21 31.12 31.40 31.30
PillTool 1 5.22 5.45 3.90 3.40 5.49
2 5.43 6.20 3.69 2.64 5.84
3 5.02 5.03 3.68 2.96 5.11
5.29 5.61 3.80 3.05 5.48
Pilomat 1 6.04 6.20 4.51 3.81 6.31
2 5.99 5.99 4.70 3.92 6.24
3 6.03 6.35 4.86 3.89 6.49





1 11.88 15.10 11.97 7.47 13.85
2 18.59 19.23 18.40 8.25 18.96
3 12.39 14.82 12.79 8.48 14.88
all 14.70 16.50 17.71 13.24 16.03
Table 1
Intra and inter accuracy of paracetamol tablets broken by hands (n = 100), several types of tablet splitters or a kitchen knife (n = 100 per device; three devices per type
investigated).
Splitting technique Number device
tested








of both parts only
Both sides
Hand broken nap 103.8 96.6 96.3 104.1 100.2
Tablet splitter Fit & healthy 1 96.3 93.6 81.4 108.5 95.0
2 108.0 80.5 74.6 113.9 94.2
3 102.5 86.9 80.2 109.2 94.7
all 102.3 87.0 87.8 101.5 94.6
Health care logistics 1 99.2 100.3 96.4 103.1 99.8
2 95.6 103.5 95.1 104.1 99.6
3 98.5 100.6 96.2 102.9 99.5
all 97.8 101.5 95.9 103.4 99.6
Lifetime 1 69.0 125.0 69.0 125.0 97.0
2 78.3 115.6 78.3 115.7 97.0
3 113.1 82.6 82.6 113.2 97.9
all 86.8 107.7 86.8 107.7 97.3
PillAid 1 59.9 132.5 59.3 133.1 96.2
2 117.2 77.6 76.8 118.0 97.4
3 119.6 78.3 77.2 120.7 98.9
all 98.9 96.1 95.7 99.3 97.5
PillTool 1 98.2 100.8 95.4 103.6 99.5
2 100.3 99.1 94.8 104.6 99.7
3 98.9 100.9 96.0 103.8 99.9
99.1 100.3 95.4 104.0 99.7
Pilomat 1 101.2 98.1 94.9 104.4 99.7
2 101.5 98.0 95.3 104.2 99.8
3 101.5 97.5 94.7 104.3 99.5
all 101.4 97.9 97.9 101.3 99.6
Kitchen knife Blokker own brand 1 100.4 94.0 87.5 106.9 97.2
2 98.34 94.5 83.2 109.6 96.4
3 104.9 92.6 88.3 109.2 98.7
all 101.2 93.7 93.3 101.6 97.5
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Fig. 2. Percent active substance for tablets subdivided by hand and three different types of tablet splitters (red left parts, blue right parts, black loss of mass). For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.
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Table 3
Compliance to regulatory requirements of paracetamol tablets following subdivision by three techniques: hand breaking, tablet splitter and kitchen knife (100 tablets
subdivided by hand; 300 tablets subdivided per type of device).
Splitting technique Uniformity of weight as adapted from Ph. Eur. 478
subdivision of tabletsa
Assay simulated as adapted from
Directive 2001/83/ECb
Loss of mass as
adapted from FDAc


















Hand broken 0 0 200 0 0 yes 103.8 96.6 yes 0 yes
Splitting
devices
Fit & Healthy 110 46 360 58 26 no 102.3 87.0 no 128 no
Health care
logistics
0 2 598 0 0 yes 97.8 101.5 yes 7 no
Lifetime 148 91 173 126 62 no 86.8 107.7 no 88 no
PillAid 149 91 149 88 123 no 98.9 96.1 yes 83 no
PillTool 0 2 598 0 0 yes 99.1 100.3 yes 6 no
Pilomat 1 8 584 7 0 no 101.4 97.9 yes 5 no
Kitchen knife Blokker own
brand
48 47 460 38 7 no 101.2 93.7 no 74 no
a Both parts of the same tablet were considered. Not less than 194 parts of 200 parts and 582 of 600 parts should be within 85–115% and all parts within 75–125% of the
theoretical (nominal) halved tablet weight (Ph. Eur. requirements: break 30 tablets by hand; take 30 parts at random and reject the other parts; not less than 29 parts should
be within 85–115% and all parts within 75–125%).
b Only parts from right / left side of the operators hands or from the right / left side of the device were considered. The average weight of the 100/300 parts should be
95.0–105.0% of the theoretical halved tablet weight.
c Loss of mass of each tablet not more than 3.0% of the theoretical intact tablet weight.
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The accuracy, precision and sustainability of three techniques
for the subdivision of paracetamol tablets were investigated: hand
breaking (n = 1 operator), tablets splitter (n = 6 types, 3 devices for
each type tested), kitchen knife (n = 1 type, 3 devices tested). The
results showed large differences and were generally best for hand
broken tablets. It was also tested whether the tablet parts complied
with three regulatory requirements adapted to the conditions of
this experiment: Ph. Eur. subdivision of tablets; assay; FDA loss of
mass. Only hand broken tablets complied with all three tests. The
devices did not deteriorate over 100-fold use. Any impact of the
type of operator or tablet characteristics on the superiority of hand
breaking over the use of a splitting device is left for future research.
The methodology was speciﬁcally developed for the aim of this
experiment. In order to limit bias to the selection of the types of tablet
splitters to be considered, we evaluated all splitters that were likely to
be used by patients living in a speciﬁed region of the Netherlands
(Utrecht) and those that could be purchased form either a community
pharmacy or a drug store. Currently, tablet splitters are not considered
as a medical device. This implies that their manufacture is outside the
control of a Notiﬁed Body i.e. the consistent performance between
several devices of the same type may not be adequately assured.
Therefore, we decided to evaluate three devices of the same type i.e. to
study the intra as well as the inter device accuracy and precision. In
addition, thereisalsonoassurancethatthedeviceswillnotdeteriorate
over repeated use. We therefore decided to evaluate the performance
of each device over common dispensing periods and dosing
frequencies i.e. 100 tablets (equalling 3 months twice daily dosing
and 2 months trice daily dosing of a half tablet).
Paracetamol was selected as the drug of choice because it is
frequently used by a wide variety of patients in the Netherlands;
because the dose for children and older people is often achieved by
subdivision of the “standard” 500 mg immediate release tablet;
becausethegeometryof this “standard” tablet (round,ﬂat, uncoated)
favours easy breaking and because the handling of large numbers of
paracetamol tablets would not involve a risk to the operator’s health
(van der Steen et al., 2010). In order to avoid any bias due to the
evaluation of a paracetamol tablet with outlier “characteristics”, we
carefully selected a trade mark with “average characteristics”.
Thereissubstantialevidencethattabletsmaynotalwaysbreakinto
two parts i.e. that tablets may break into several pieces or showgrinding. In such cases the difference in theweight of one tablet part to
the half of the intact tablet weight may differ from the other part and
consequently, the accuracyand precision may depend on the selection
of the tablet parts that are considered in the data analysis. In order to
evaluate any impact of the selection of the tablet parts on the results of
this experiment, we decided to evaluate ﬁve pre-deﬁned approaches.
These approaches were based on the following considerations 1) the
possibilitytostudyanyimpactofthekeycharacteristicsof thesplitting
devices on the accuracy, precision, sustainability of the devices; 2)
current clinical practices where large numbers of tablets are broken at
the same time and put back into the container as if they were single
dose units; 3) current clinical practices where both parts from the
same tablet may not be given to the same patient.
In this experiment, the accuracies and precisions were
calculated on basis of the theoretical weight of an intact tablet
rather than the weight of each tablet itself prior to subdivision. This
approach was considered acceptable in view of the low variability
in the weight of 100 intact tablets (0.7%).
The differences in the accuracy and precision of the tablet
splitters could not be explained by their design and price: although
some splitters looked the same, their accuracy and precision were
quite different and the most expensive tablet splitters were not
always the best. One of the tablet splitters had a knife that was
sharp on one side only. By visual examination, it turned out that the
sharp end was at the left side for two splitters and at the right side
for the third splitter. A correction for this aspect was implemented
in the General Linear model and Dunnet’s analysis.
This experiment showed that tablet splitters and a kitchen knife
may not accurately and precisely subdivide tablets into equal parts.
This result is consistent with ﬁndings from other authors (Freeman
et al., 2012a; Shah et al., 2010; Tahaineh and Gharaibeh, 2012).
However, in contrary to their studies, this experiment tested several
types of tablet splitters and a kitchen knife over 100-fold use
applying a best case drug, tablet and operator, and allowing
comparison of the results with those of tablets broken by hand. In
addition, three devices of each type were considered as well as the
impactofﬁve differentapproaches tothe selection of the tabletparts.
Health care professionals may consider to study the dosing
accuracy and precision of a speciﬁc type of tablet splitter in relation
to a speciﬁed medicine if such a medicine must be subdivided by a
splitting device. However, such studies will only be of any value to
the patient when the results show consistent and acceptable intra
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depend on the selection of the tablet parts that were considered in
the data analysis. This investigation showed that these conditions
were only met by the Health Care Logistics splitter when applying a
range of 95.0–105.0 for accuracy and a maximum of 5.0% for
precision, and also by the PilTool and Pilomat splitter when
applying a slightly lower treshold for accuracy of 94.7% and a
higher threshold of 6.5% for the precision.
This experiment has some limitations. Firstly, only a “best case”
tablet with “average” hardness was studied. It was assumed that
smaller, convex, verysoft or very hard tablets would be moredifﬁcult
to break into two equal parts by hand than the selected paracetamol
tablets and that such smaller, convex, very soft, or very hard tablets
would also be more difﬁcult to subdivide with a splitting device. The
included tablet splitters were dispensed without any restrictions to
the type of tablets for which the splitters could be used. We therefore
considered that the tablet splitters and the kitchen knife should be
suitable forany tablet type, especially “best case”. Thus, the impact of
tablet geometry and hardness on the accuracy and precision of
splitting devices is left for future research for those with adequate
accuracy and precision with a best case tablet only.
Secondly, this experiment was conducted by a “best case”
operator. However, the ability to break tablets by hand and
correctly use a splitting device is known to decline with certain
patient characteristics such as impaired hand function, limited
visibility or mental retardation. It is unlikely that the effect of such
changes on the accuracy and precision of tablet subdivision will
show a similar pattern between the three techniques e.g. people
with trembling hands may be well able to use a tablet splitter but
not a kitchen knife. The evaluated tablet splitters were dispensed
without any restrictions to the operator. In the Netherlands, tablet
splitters and kitchen knives are commonly used by health care
professionals and caregivers who need to subdivide large numbers
of tablets. We therefore considered that splitting devices should be
suitable for any patient population. Thus the impact of patient
characteristics on the accuracy and precision of splitting devices is
left for future research for those showing adequate accuracy and
precision with a best case operator only.
None of the splitting devices meet the regulatory requirements
as adapted for this experiment. As our criteria are reasonable and
our results cannot be explained by a poor performing operator, we
consider that the device industry should develop better tablet
splitters.
In view of the high potential of intended or unintended off-label
breaking, we advise the pharmaceutical industry to assure precise
andaccuratebreakingofall breakmarked tablets irrespective of their
posologyand user instruction i.e. irrespective as to whether breaking
needsto beapprovedby the regulatoryauthoritiesornot. Inaddition,
the pharmaceutical industry is recommended to assure that the
majority of the indicated patient populations will be able to break
tablets by hand without any relevant difﬁculties or discomfort.
We urge authorities to undertake measures to assure that only
tablet splitters with an acceptable accuracy, precision and
sustainability can enter the market. In addition, the ease, accuracy
and precision of breaking tablets by hand should be evaluated
during the licensing process (new applications) and appropriate
measures should be considered for break mark tablets that are
already on the market. The development of a standardised
methodology for the ease of tablet breaking would be welcomed.
Such a test may be included in the Ph. Eur. In addition, incentives
may be aimed at the development and authorisation of additional
dosage forms that allow ﬂexible dosing and easy swallowing such
as oral liquids, sprinkles and mini-tablets (Klingmann et al., 2013;
van Riet-Nales et al., 2013).
The development of an international harmonized methodology
for the subdivision of tablets with a tablet splitter is recommendedalso. As this experiment showed that the accuracy and precision
may depend on the selection of the tablet parts to be considered in
the data analysis, such a test preferably includes a predeﬁned
approach to the selection strategy.
Health care professionals, patients and caregivers should
realize that tablet splitting may result in dosing inaccuracies,
which may have an effect on clinical outcomes. They should also
remember that the subdivision of tablets is likely to go with any
loss of mass and that even a small loss (“dust”) may be potentially
harmful to the patient’s environment depending on the type of
active substance that the tablet contains e.g. in case of subdivision
of mercaptopurin tablets for paediatric dosing in a domestic
setting (Breitkreutz et al., 2007). Thus, patients should tell their
nurses, doctors and pharmacists that they have difﬁculties (hand)
breaking or swallowing tablets. Together they should consider
alternative treatment options. These considerations may result in
the continuation of the tablet splitter, however if so, the best
available device should be used.
5. Conclusions
The accuracy and precision of none of the investigated tablet
splitters and kitchen knife was equivalent to hand breaking when
applying a best case drug, tablet and operator. Health care
professionals and patients should realize that tablet splitting may
result in inaccurate dosing. Authorities should undertake measures
to assure good function of tablet splitters and, where feasible, to
reduce the need for their use. The devices did not deteriorate over
100-fold use.
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